Primary clinical effects of PP therapy (cisplatin and peplomycin) and TPP therapy (4′-O-tetrahydropyranyladriamycin, cisplatin and peplomycin) for oral cancer

[1]  K. Kaga,et al.  [Combined CDDP-THP-PEP chemotherapy (PTP therapy) for head and neck squamous cell carcinoma--a group study]. , 1994, Gan to kagaku ryoho. Cancer & chemotherapy.

[2]  H. Fukuda,et al.  Combined intra-arterial chemotherapy with TPP (THP-ADM, CDDP, PEP) for oral squamous cell carcinomas , 1993 .

[3]  T. Kaneda,et al.  [Primary clinical effects of chemotherapy mainly with cisplatin, peplomycin (PP therapy) against head and neck cancer--the multi-institutional joint research in Tokai district]. , 1987, Nihon Gan Chiryo Gakkai shi.

[4]  M. Hirano,et al.  [Histological effects of cis-platinum-peplomycin induction chemotherapy for head and neck carcinomas]. , 1985, Nihon Gan Chiryo Gakkai shi.

[5]  S. Mashino.  [Effect of the combination of cisplatin and peplomycin on Ehrlich ascites carcinoma and on head and neck squamous cell carcinoma transplanted to nude mice]. , 1985, Nihon Jibiinkoka Gakkai kaiho.

[6]  M. Fujii.  [Fundamental study on the combination therapy of cisplatin and peplomycin]. , 1985, Nihon Jibiinkoka Gakkai kaiho.

[7]  A. Matsuda,et al.  [Experimental studies on combination chemotherapy of cisplatin with peplomycin against human squamous cell carcinomas in nude mice]. , 1985, Gan to kagaku ryoho. Cancer & chemotherapy.

[8]  R. Diasio,et al.  cis-Platinum in gynecologic cancer , 1981 .

[9]  R. Diasio,et al.  cis-Platinum in gynecologic cancer. II. Squamous cell carcinoma of the cervix. , 1981, American journal of obstetrics and gynecology.

[10]  R. Weichselbaum,et al.  Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM). , 1981, Cancer treatment reports.

[11]  T. Fleming,et al.  Cyclophosphamide, adriamycin, and cis‐diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancer , 1981, Cancer.

[12]  Y. Takahashi,et al.  Tetrahydropyranyl derivatives of daunomycin and adriamycin. , 1979, The Journal of antibiotics.

[13]  C. Merrin.  Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients. , 1979, Cancer treatment reports.

[14]  R. Wittes,et al.  CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck. , 1977, Cancer treatment reports.

[15]  Coltman Ca,et al.  Phase II evaluation of cis-diamminedichloroplatinum(II) in lung cancer. , 1976 .

[16]  E. Wiltshaw,et al.  Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary. , 1976, Cancer treatment reports.

[17]  R. Wittes,et al.  Combination Chemotherapy with cis-Diamminedichloroplatinum (II) and Bleomycin in Tumors of the Head and Neck , 1975 .

[18]  L. Helson,et al.  Clinical trials of cis-diamminedichloroplatinum (NSC-119875). , 1973, Cancer chemotherapy reports.

[19]  BARNETT ROSENBERG,et al.  Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode , 1965, Nature.